Currenc Group, Inc. (CURR) Financials
CURR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2025 | 86.9 million | 62.2 million |
| June 30, 2025 | 94.5 million | 127.4 million |
| March 31, 2025 | 110.8 million | 154.7 million |
| Dec. 31, 2024 | 108.5 million | 150.2 million |
CURR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2025 | -8.5 million | -1.1 million |
| June 30, 2025 | -2.3 million | 2.2 million |
| March 31, 2025 | -1.7 million | 2.2 million |
| Dec. 31, 2024 | 14.5 million | 7.7 million |
CURR Net Income
No data available :(
CURR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2025 | 50.7 million | - | 17259 |
| June 30, 2025 | 61.3 million | - | 230887 |
| March 31, 2025 | 65.5 million | - | 289338 |
| Dec. 31, 2024 | 63.8 million | - | 328556 |
CURR Shares Outstanding
CURR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2025 | 300591 | - | 519576 | - |
| June 30, 2025 | 125435 | - | 7.6 million | - |
| March 31, 2025 | 175158 | - | 7.5 million | - |
| Dec. 31, 2024 | 576674 | - | 11.9 million | - |
CURR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2025 | 10.4 million | 5.1 million |
| June 30, 2025 | 8.7 million | 5.5 million |
| March 31, 2025 | 10.1 million | 6.9 million |
| Dec. 31, 2024 | 11.1 million | 7.8 million |
CURR
Price: $3.36
52 week price:
Earnings Per Share: -0.85 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 204.5 million